[go: up one dir, main page]

CL2016001204A1 - Composiciones y métodos para la mejora de la función pulmonar. - Google Patents

Composiciones y métodos para la mejora de la función pulmonar.

Info

Publication number
CL2016001204A1
CL2016001204A1 CL2016001204A CL2016001204A CL2016001204A1 CL 2016001204 A1 CL2016001204 A1 CL 2016001204A1 CL 2016001204 A CL2016001204 A CL 2016001204A CL 2016001204 A CL2016001204 A CL 2016001204A CL 2016001204 A1 CL2016001204 A1 CL 2016001204A1
Authority
CL
Chile
Prior art keywords
compositions
improvement
methods
lung function
iodine
Prior art date
Application number
CL2016001204A
Other languages
English (en)
Inventor
Staffan Skogvall
Original Assignee
Pharmalundensis Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=51945878&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CL2016001204(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Pharmalundensis Ab filed Critical Pharmalundensis Ab
Publication of CL2016001204A1 publication Critical patent/CL2016001204A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/18—Iodine; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/20—Elemental chlorine; Inorganic compounds releasing chlorine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/44—Elemental carbon, e.g. charcoal, carbon black
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/501—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pulmonology (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

COMPOSICION FARMACEUTICA QUE MEJORA LA FUNCION PULMONAR QUE COMPRENDE CARBON ACTIVADO, YODO ADSORBIDO (I2) Y/O UNA SAL DE YODO ADSORBIDO Y UN INHIBIDOR DEL SIMPORTADOR SODIO/YODO; METODO PARA MEJORAR LA FUNCION PULMONAR QUE COMPRENDE LA ADMINISTRACION DE LA COMPOSICION; UN KIT
CL2016001204A 2013-11-20 2016-05-19 Composiciones y métodos para la mejora de la función pulmonar. CL2016001204A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE1351373 2013-11-20

Publications (1)

Publication Number Publication Date
CL2016001204A1 true CL2016001204A1 (es) 2016-12-02

Family

ID=51945878

Family Applications (1)

Application Number Title Priority Date Filing Date
CL2016001204A CL2016001204A1 (es) 2013-11-20 2016-05-19 Composiciones y métodos para la mejora de la función pulmonar.

Country Status (11)

Country Link
US (2) US9943542B2 (es)
EP (1) EP3071233B1 (es)
JP (1) JP6521968B2 (es)
KR (1) KR20160141703A (es)
CN (1) CN105873610A (es)
CL (1) CL2016001204A1 (es)
IL (1) IL245693B (es)
RU (1) RU2016123975A (es)
SA (1) SA516371143B1 (es)
WO (1) WO2015075111A1 (es)
ZA (1) ZA201603112B (es)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6024882A (en) * 1997-08-08 2000-02-15 Applied Process Technology, Inc. Process and apparatus for water decontamination
DK2222314T3 (da) * 2007-11-23 2013-04-15 Pharmalundensis Ab Anvendelser og midler til opnåelse af bronchorelaxation
WO2009078782A1 (en) 2007-12-19 2009-06-25 Pharmalundensis Ab Method and means for producing bronchorelaxation

Also Published As

Publication number Publication date
WO2015075111A1 (en) 2015-05-28
ZA201603112B (en) 2017-08-30
US20160271170A1 (en) 2016-09-22
US9943542B2 (en) 2018-04-17
EP3071233B1 (en) 2018-11-07
IL245693B (en) 2018-06-28
RU2016123975A (ru) 2017-12-25
JP6521968B2 (ja) 2019-05-29
JP2017500294A (ja) 2017-01-05
CN105873610A (zh) 2016-08-17
SA516371143B1 (ar) 2018-11-28
KR20160141703A (ko) 2016-12-09
US20180200292A1 (en) 2018-07-19
EP3071233A1 (en) 2016-09-28
IL245693A0 (en) 2016-06-30

Similar Documents

Publication Publication Date Title
DOP2020000102A (es) Compuestos útiles para inhibir a cdk7
CY1121928T1 (el) Φαρμακευτικη συνθεση υδροχλωρικης s-κεταμινης
AR110381A2 (es) Inhibidores biarilo de tirosina cinasa de bruton
DK3328843T3 (da) 1,3,4-oxadiazolsulfonamidderivat-forbindelser som histon- deacetylase-6-inhibitor, og den farmaceutske sammensætning
EA202090683A3 (ru) Способы и композиции для лечения рака
CY1119042T1 (el) Υποκατεστημενες ξανθινες και μεθοδοι χρησης αυτων
CL2017000902A1 (es) Dihidropirrolopiridinas inhibidoras de ror-gamma
CR20160499A (es) Composiciones estables de yodo no en complejo y métodos de uso
DK3330259T3 (da) 1,3,4-oxadiazolamidderivativ-forbindelse som histondeacetylase-6-inhibitor og farmaceutisk sammensætning indeholdende denne
EA201591137A1 (ru) Ингибиторы mk2 и их применения
EA201692301A1 (ru) Производные бороновой кислоты и их терапевтическое применение
MX2020011104A (es) Composiciones farmaceuticas de compuestos terapeuticamente activos y sus metodos de uso.
AR098168A1 (es) Formulación estable de insulina glulisina
CY1120535T1 (el) Δοτες νιτροξυλιου με βελτιωμενο θεραπευτικο δεικτη
MX2017003205A (es) Composiciones antimicrobianas y sus metodos de uso.
EA201591712A1 (ru) Антибиотические композиции на основе цефтолозана
MX379367B (es) Kit para marcaje radiactivo con galio 68 (68ga) que comprende un inhibidor de metal.
MX2016008429A (es) Derivado de piranocromenil fenol, y composicion farmaceutica para tratar un sindrome metabolico o enfermedad inflamatoria.
WO2014153009A3 (en) Thiosaccharide mucolytic agents
AU2018253594A1 (en) Dihydroxyphenyl neurotransmitter compounds, compositions and methods
PH12017500348B1 (en) Tetrahydroquinoline derivatives as bromodomain inhibitors
BR112015032526A2 (pt) composições anticaspa e métodos de uso das mesmas
UY36173A (es) Metodo de tratamiento de enfermedades relacionadas con el factor inducible por hipoxia
DOP2017000014A (es) Métodos para mejorar el rendimiento miocárdico en pacientes con cirugía de fontan que utilizan composiciones de udenafilo
MX2017002737A (es) Farmaceutico que contiene inhibidor de transportador de fosfato dependiente de sodio.